7Strategy, Rate and Maxima in the Clinic

CChoosing the strategy family without re-teaching the theory

Contemporary Cochlear devices default to ACE, an n-of-m strategy that selects the n highest-amplitude channels each cycle, while Advanced Bionics defaults to a HiRes family and MED-EL to an FSP/FS4 family that varies low-frequency rate to track the input signal. Most Nucleus recipients perform as well or better with ACE than with the older fixed-rate SPEAK strategy, which is why ACE remains the routine clinical default. The clinician usually only switches strategy family for a specific reason, for example moving a Nucleus user from ACE (monopolar) to SPEAK if monopolar stimulation produces facial-nerve stimulation and bipolar coupling is needed. Strategy selection at first fit is rarely the lever that fixes poor outcomes; rate, maxima, levels and front-end settings are adjusted far more often than the base strategy is changed. n-of-m peak-picking discards low-amplitude channels each cycle, which buys faster per-channel rates, less channel interaction and longer battery life, at the theoretical cost of dropping information that fails to reach selection threshold.[2020][2002][2014]

TStimulation rate: faster is not reliably better

Stimulation rate is the number of biphasic pulses delivered to a single channel per second; the earliest multichannel devices ran at 250 pulses per second or below, while contemporary systems allow up to roughly 5000. Faster rates tend to sound louder through temporal summation and slightly higher in pitch as rate climbs from about 50 to 500 Hz, so a rate change is also a loudness change that must be re-balanced. The largest controlled trial (71 Nucleus Freedom users, rates 500 to 3500 pulses per second) found no significant speech-recognition difference across rates, and recipients tended to prefer the slower rates of 500 to 1800 over 2400 to 3500. Across multiple studies, rates above approximately 1500 pulses per second do not reliably improve speech recognition in quiet or in noise, and the consistent conclusion is that the optimal rate varies by individual. The Cochlear ACE default is 900 pulses per second per channel; very high rates demand very narrow pulse widths that can hit voltage-compliance limits before adequate loudness is reached.[2020][2007][2014]

TMaxima and the per-channel rate they imply

Maxima (the n in n-of-m) is the number of channels stimulated per analysis cycle; in ACE and SPEAK it typically ranges from 8 to 12, with a 22-channel program at maxima 10 firing the 10 highest-amplitude channels and skipping the rest. Because the total stimulation budget is fixed (the first ACE version capped total rate near 14400 pulses per second), fewer maxima frees rate for each active channel: 8 maxima within a 14400 budget yields 1800 per channel. Cochlear's ACE default is 8 maxima at 900 pulses per second, but many clinicians routinely raise maxima to 10 to provide more spectral detail, accepting the implied per-channel rate consequences. SPEAK fixes rate near 250 pulses per second and typically uses a maxima of 8 out of up to 20 active channels, which is why it is the fallback when very low, bipolar-style stimulation is required. Reducing maxima improves signal efficiency and battery life proportionally, which is the rationale behind variants that discard channels predicted to be masked.[2020][2014][2002]

CPulse width, the rate ceiling, and individualised tuning

Pulse width (phase duration) is the duration of each phase of the biphasic pulse, measured in microseconds, typically about 10 to 100, and loudness scales with the product of current amplitude and pulse width. When a recipient cannot reach a comfortable loudness at the device's current-output ceiling (often with high impedances or high C levels), the clinician widens the pulse width rather than pushing current; a common first move is 25 to 50 microseconds. Wider pulse widths consume more of the per-cycle time budget, so they cap how fast and how many channels can be stimulated, a direct trade-off between phase duration and achievable rate and maxima. Because the individual optimum for rate and maxima varies, the practical clinic approach is to keep the recipient on validated defaults, change one parameter at a time, and confirm any change against sound-field detection, speech testing and the recipient's own preference. Even in trials where group means show no benefit from faster rates, a minority of individuals demonstrably perform or prefer better at a non-default rate, supporting individualised optimisation rather than a one-size default.[2020][2007][2002][2014]